Alvotech Announces Approval of AVT03, a Biosimilar to Prolia(R) and Xgeva(R) (denosumab) in the European Economic Area

(NasdaqGM:ALVO),(Nasdaq First North Iceland:ALVO),(Stockholm:ALVO SDB), REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission (EC) has approved AVT03 as a biosimilar to Prolia(R) and Xgeva(R) (denosumab). The European denosumab market is […]

Byreal Platform Update Slashes LP Costs by 95%, Adds Social Sharing for Liquidity Farming

Byreal, a decentralized exchange incubated by Bybit and built for the Solana ecosystem, announced a package of comprehensive platform upgrades designed to enhance liquidity efficiency and user experience. The upgrades include the introduction of Dynamic Tick Array technology, significant product and performance optimizations, and the recent launch of the social referral feature for Real Farmer,

Triple the Probiotics, Triple the Relief: Life-Space Launches Triple Strength Probiotics in Southeast Asia

Engineered by Australia's leading probiotics expert, this highCFU probiotic delivers the ultimate gut defense, helping to reduce gut transit time by up to 18 hours. Life-Space, Australia's No.1probiotic brand, proudly unveils Triple Strength Probiotics, a flash charged probiotic designed to deliver intensive gut health support for those with more demanding digestive needs. With 15 premium

Invitation to FluoGuide A/S (Nasdaq: FLUO) Webcast on 27 November 2025

KØBENHAVN, DK / ACCESS Newswire / November 24, 2025 / FluoGuide A/S (STO:FLUO) – FluoGuide A/S will publish its Interim Report Q3 2025 on Thursday 27 November 2025. The following event will take place later that day: A live webcast for shareholders, analysts, investors and representatives of the media: Topic: FluoGuide Operational and Financial Results

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia(R) and Xgeva(R) (denosumab) in the European Economic Area

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia(R) and Xgeva(R) (denosumab) in the European Economic Area GlobeNewswire November 24, 2025 REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission (EC)

Chuangxin Industries Holdings Limited Debuts on Hong Kong Stock Exchange Today

On 24 November, Chuangxin Industries Holdings Limited ('Chuangxin Industries' or the 'Company', 02788.HK), a leading integrated producer of electrolytic aluminum and alumina in China, was officially listed on the Main Board of the Hong Kong Stock Exchange. The Company offered a total of 500 million shares globally, with approximately 10% under the Hong Kong Public

Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries

Hollister Incorporated, a global leader in healthcare products and services, proudly announces agroundbreaking policy shift benefiting thousands of Medicare beneficiaries living with spinal cord injuries (SCI). In a landmark victory for patient advocacy, the Durable Medical Equipment Medicare Administrative Contractor's (DME MACs) have agreed to expand access to closed system intermittent catheters-critical medical devices proven

Drs. Elliott Brea, Esther Redin, and Gavitt Woodard Announced as Recipients of LUNGevity’s Career Development Awards

Prestigious award supports a strong oncology workforce to create lifesaving lung cancer breakthroughs LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit, is proud to announce the recipients of their 2025 Career Development Awards. https://mma.prnewswire.com/media/2037636/LUNGevity_updated_Logo.jpg Established in 2012, LUNGevity's Career Development Awards have been a steadfast source of support for junior investigators who are passionate about

Salimetrics Launches ‘Tools for Your Toolbox’ to Improve Research Study Management

Building on the Salimetrics CoreLab+ research testing platform, Salimetrics announces the launch of its valuable organization, logistics, and statistical data tools to help investigators improve the efficiency of saliva and dried blood spot biomarker-based studies. https://mma.prnewswire.com/media/2830049/Salimetrics_Logo.jpg With expanded resources designed for early-stage research planning, Salimetrics is increasing support for investigators at a time when support

Pepington Unveils $SKELLP: A New Festive-Meme Token Targeting Massive 2025 Growth

Dubai, UAE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Pepington, a fresh and fast-rising meme-coin project, has officially unveiled $SKELLP, a festive-themed token inspired by the quirky and humorous crossover of holiday vibes and the iconic “Skellington Frog.” Positioned at the intersection of seasonal culture, humor, and Web3 enthusiasm, Pepington aims to energize the meme coin

Scroll to Top